Overview
Clinical Benefits
- Boosts T-cell immunity
- Antiviral properties
- Reduces chronic inflammation
- Supports immune recovery
Administration
Subcutaneous injection
Drug class: thymic peptide
Clinical Dosing
Typical dosage
1.6mg
Starting dose
0.8mg
Cadence
2x weekly
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-2 | 0.8mg twice weekly |
| Weeks 3+ | 1.6mg twice weekly |
Safety Profile
Side effects
- • Injection site redness
- • Fatigue (temporary)
Contraindications
- • Organ transplant recipients
- • Autoimmune conditions (use with caution)
Featured in these stacks
Stack 02
Elite DirectThe Repairman
The repair crew after Stack 01 primes your cells
Thymosin Alpha-1 — restores thymic-mediated immune signaling so the tissue gains are protected.
View stack
Stack 05
Elite DirectThe Fountain of Youth
Build the architecture of biological age reversal
Thymosin Alpha-1 — restores thymic-mediated immune signaling; the strongest human biomarker data in the longevity space.
View stack
Stack 10
Elite DirectRadiance
Inside-out cellular renewal
Thymosin Alpha-1 — protects the aesthetic gains from immune / inflammatory setbacks.
View stack
Frequently asked questions
Thymosin Alpha-1 is most commonly researched for: Boosts T-cell immunity, Antiviral properties, Reduces chronic inflammation, Supports immune recovery.
Ready to build a protocol with Thymosin Alpha-1?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.